FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells

Stem Cell Reports

Volumn 3, Issue 5, 2014, Pages 699-706

  Avitzour, Michal ^a   Mor Shaked, Hagar ^a   Yanovsky Dagan, Shira ^a   Aharoni, Shira ^a   Altarescu, Gheona ^a   Renbaum, Paul ^a   Eldar Geva, Talia ^a   Schonberger, Oshrat ^a   Levy Lahad, Ephrat ^a   Epsztejn Litman, Silvina ^a   Eiges, Rachel ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR CTCF; 5' UNTRANSLATED REGION; FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; HISTONE; LYSINE; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

5' UNTRANSLATED REGION; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EPIGENETICS; FEMALE; FMR1 GENE; FRAGILE X SYNDROME; GENE; GENE SILENCING; GENETIC LINKAGE; HUMAN; HUMAN CELL; MALE; METHYLATION; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; CELL LINE; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEAT; WESTERN BLOTTING; X CHROMOSOME INACTIVATION;

5' UNTRANSLATED REGIONS; BLOTTING, WESTERN; CELL LINE; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION; GENE SILENCING; HISTONES; HUMANS; LYSINE; METHYLATION; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SOXB1 TRANSCRIPTION FACTORS; TRINUCLEOTIDE REPEAT EXPANSION; X CHROMOSOME INACTIVATION;

EID: 84922571389     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.09.001     Document Type: Article

References (29)

1. Castellví-Bel, S., Milà, M., Soler, A., Carrió, A., Sánchez, A., Villa, M., Jiménez, M.D., and Estivill, X. (1995). Prenatal diagnosis of fragile X syndrome: (CGG)n expansion and methylation of chorionic villus samples. Prenat. Diagn. 15, 801-807.
2. Coffee, B., Zhang, F., Warren, S.T., and Reines, D. (1999). Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22, 98-101.
3. Coffee, B., Zhang, F., Ceman, S., Warren, S.T., and Reines, D. (2002). Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am. J. Hum. Genet. 71, 923-932.
4. Colak, D., Zaninovic, N., Cohen, M.S., Rosenwaks, Z., Yang, W.Y., Gerhardt, J., Disney, M.D., and Jaffrey, S.R. (2014). Promoterbound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 343, 1002-1005.
5. Devys, D., Biancalana, V., Rousseau, F., Boué, J., Mandel, J.L., and Oberlé, I. (1992). Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am. J. Med. Genet. 43, 208-216.
6. Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A., Yaron, Y., Eden, A., Yanuka, O., Benvenisty, N., and Ben-Yosef, D. (2007). Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1, 568-577.
7. Godler, D.E., Tassone, F., Loesch, D.Z., Taylor, A.K., Gehling, F., Hagerman, R.J., Burgess, T., Ganesamoorthy, D., Hennerich, D., Gordon, L., et al. (2010). Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum. Mol. Genet. 19, 1618-1632.
8. Kiedrowski, L.A., Raca, G., Laffin, J.J., Nisler, B.S., Leonhard, K., McIntire, E., and Mongomery, K.D. (2011).DNAmethylation assay for X-chromosome inactivation in female human iPS cells. Stem Cell Rev. 7, 969-975.
9. Kremer, E.J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S.T., Schlessinger, D., Sutherland, G.R., and Richards, R.I. (1991). Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711-1714.
10. Kumari, D., and Usdin, K. (2010). The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum. Mol. Genet. 19, 4634-4642.
11. Ladd, P.D., Smith, L.E., Rabaia, N.A., Moore, J.M., Georges, S.A., Hansen, R.S., Hagerman, R.J., Tassone, F., Tapscott, S.J., and Filippova, G.N. (2007). An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 16, 3174-3187.
12. Lanni, S., Goracci, M., Borrelli, L., Mancano, G., Chiurazzi, P., Moscato, U., Ferrè, F., Helmer-Citterich, M., Tabolacci, E., and Neri, G. (2013). Role of CTCF protein in regulating FMR1 locus transcription. PLoS Genet. 9, e1003601.
13. Nolin, S.L., Lewis, F.A., 3rd, Ye, L.L., Houck, G.E., Jr., Glicksman, A.E., Limprasert, P., Li, S.Y., Zhong, N., Ashley, A.E., Feingold, E., et al. (1996). Familial transmission of the FMR1 CGG repeat. Am. J. Hum. Genet. 59, 1252-1261.
14. Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M.F., and Mandel, J.L. (1991). Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102.
15. Pietrobono, R., Tabolacci, E., Zalfa, F., Zito, I., Terracciano, A., Moscato, U., Bagni, C., Oostra, B., Chiurazzi, P., and Neri, G. (2005). Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum. Mol. Genet. 14, 267-277.
16. Rousseau, F., Heitz, D., Biancalana, V., Blumenfeld, S., Kretz, C., Boué, J., Tommerup, N., Van Der Hagen, C., DeLozier-Blanchet, C., Croquette, M.F., et al. (1991). Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N. Engl. J. Med. 325, 1673-1681.
17. Santoro, M.R., Bray, S.M., and Warren, S.T. (2012). Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu. Rev. Pathol. 7, 219-245.
18. Shen, Y., Matsuno, Y., Fouse, S.D., Rao, N., Root, S., Xu, R., Pellegrini, M., Riggs, A.D., and Fan, G. (2008). X-inactivation in female human embryonic stem cells is in a nonrandompattern and prone to epigenetic alterations. Proc. Natl. Acad. Sci. USA 105, 4709-4714.
19. Sheridan, S.D., Theriault, K.M., Reis, S.A., Zhou, F., Madison, J.M., Daheron, L., Loring, J.F., and Haggarty, S.J. (2011). Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE 6, e26203.
20. Sutcliffe, J.S., Nelson, D.L., Zhang, F., Pieretti, M., Caskey, C.T., Saxe, D., and Warren, S.T. (1992). DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1, 397-400.
21. Sutherland, G.R., Gedeon, A., Kornman, L., Donnelly, A., Byard, R.W., Mulley, J.C., Kremer, E., Lynch, M., Pritchard, M., Yu, S., and Richards, R.I. (1991). Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N. Engl. J. Med. 325, 1720-1722.
22. Suzumori, K., Yamauchi, M., Seki, N., Kondo, I., and Hori, T. (1993). Prenatal diagnosis of a hypermethylated full fragile X mutation in chorionic villi of a male fetus. J. Med. Genet. 30, 785-787.
23. Tabolacci, E., Pietrobono, R., Moscato, U., Oostra, B.A., Chiurazzi, P., and Neri, G. (2005). Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur. J. Hum. Genet. 13, 641-648.
24. Tabolacci, E., Moscato, U., Zalfa, F., Bagni, C., Chiurazzi, P., and Neri, G. (2008). Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur. J. Hum. Genet. 16, 1487-1498.
25. Tassone, F., Hagerman, R.J., Taylor, A.K., and Hagerman, P.J. (2001). A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J. Med. Genet. 38, 453-456.
26. Telias, M., Segal, M., and Ben-Yosef, D. (2013). Neural differentiation of Fragile X human Embryonic Stem Cells reveals abnormal patterns of development despite successful neurogenesis. Dev. Biol. 374, 32-45.
27. Urbach, A., Bar-Nur, O., Daley, G.Q., and Benvenisty, N. (2010). Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6, 407-411.
28. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
29. Yu, S., Pritchard, M., Kremer, E., Lynch, M., Nancarrow, J., Baker, E., Holman, K., Mulley, J.C., Warren, S.T., Schlessinger, D., et al. (1991). Fragile X genotype characterized by an unstable region of DNA. Science 252, 1179-1181.